The cholinergic system in alzheimer's disease

Progress in Neurobiology

Volumn 52, Issue 6, 1997, Pages 511-535

  Kása, Peter ^a   Rakonczay, Zoltan ^a   Gulya, Karoly ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE ACETYLTRANSFERASE;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; BRAIN CORTEX; CHOLINERGIC SYSTEM; ENTORHINAL CORTEX; ENZYME INHIBITION; ENZYME LOCALIZATION; HIPPOCAMPUS; HUMAN; NEUROTRANSMITTER RELEASE; OLFACTORY BULB; PRIORITY JOURNAL; RETICULAR FORMATION; REVIEW;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; BRAIN; CHOLINE O-ACETYLTRANSFERASE; CHOLINESTERASES; HUMANS; PARASYMPATHETIC NERVOUS SYSTEM; RECEPTORS, CHOLINERGIC;

EID: 0030767243     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(97)00028-2     Document Type: Review

References (265)

1. Alheid, G., Heimer, L. and Switzer, R. C. (1990) Basal ganglia. In: The Human Nervous System, pp. 483-582. Ed. G. Paxinos. Academic Press: New York.
2. Amaral, D. G. and Insausti, R. (1990) Hippocampal formation. In: The Human Nervous System, pp. 711-755. Ed. G. Paxinos. Academic Press: New York.
3. Araujo, D. M. and Lapchak, P. A. (1994) Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors. Neuroscience 61, 745-754.
4. Araujo, D. M., Lapchak, P. A., Robitaille, Y., Gauthier, S. and Quirion, R. (1988) Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J. Neurochem. 50, 1914-1923.
5. Arendt, T., Bigl, A., Arendt, A. and Tennstedt, A. (1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease. Acta Neuropath. 61, 101-108.
6. Arendt, T., Bigl, V., Tennstedt, A. and Arendt, A. (1984) Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease. Neurosci. Lett. 48, 81-85.
7. Arendt, T., Bigl, V., Tennstedt, A. and Arendt, A. (1985) Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease. Neuroscience 14, 1-14.
8. Arendt, T., Bruckner, M., Lange, M. and Bigl, V. (1992) Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development: a study of molecular forms. Neurochem. Int. 21, 381-396.
9. Atack, J. R., Perry, E. K., Bonham, J. R., Perry, R. H., Tomlinson, B. E., Blessed, G. and Fairbairn, A. (1983) Molecular forms of acetylcholinesterase in senile dementia of Alzheimer's type: selective loss of the intermediate (10S) form. Neurosci. Lett. 40, 199-204.
10. Aubert, I., Araujo, D. M., Cécyre, D., Robitaille, Y., Gauthier, S. and Quirion, R. (1992) Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J. Neurochem. 58, 529-541.
11. Averback, P. (1983) Two new lesions in Alzheimer's disease. Lancet ii, 1203.
12. Bartus, R. T., Dean, R. L., Beer, B. and Lippa, A. S. (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-417.
13. Bartus, R. T., Dean, R. L., Pontecorvo, M. J. and Flicker, C. (1985) The cholinergic hypothesis: a historical overview, current perspective, and future directions. Ann. N.Y. Acad. Sci. 444, 332-358.
14. Benzing, W. C., Mufson, E. J. and Armstrong, D. M. (1993) Immunocytochemical distribution of peptidergic and cholinergic fibers in the human amygdala: their depletion in Alzheimer's disease and morphologic alteration in non-demented elderly with numerous senile plaques. Brain Res. 625, 125-138.
15. Bierer, L. M., Haroutunian, V., Gabriel, S., Knott, P. J., Carlin, L. S., Purohit, D. P., Perl, D. P., Schmeidler, J., Kanof, P. and Davis, K. L. (1995) Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J. Neurochem. 64, 749-760.
16. Bonner, T. I. (1989) The molecular basis of muscarinic receptor diversity. Trends Neurosci. 12, 148-151.
17. Bonner, T. I., Buckley, N. J., Young, A. C. and Brann, M. R. (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science 237, 527-532.
18. Bonner, T. I., Young, A. C., Brann, M. R. and Buckley, N. J. (1988) Cloning and expression of the human and rat m5 muscarinic acetylcholine genes. Neuron 1, 403-410.
19. Boulter, J., Connoly, J., Deneris, E., Goldman, D., Heinemann, S. and Patrick, J. (1987) Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family. Proc. natn. Acad. Sci. U.S.A. 84, 7763-7767.
20. Bowen, D. M. and Davison, A. N. (1980) Biochemical changes in the cholinergic system of the ageing brain and in senile dementia. Psychol. Med. 10, 315-319.
21. Bowen, D. M., Smith, C. B., White, P. and Davison, A. N. (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99, 459-496.
22. Bowen, D. M., White, P., Spillane, J. A., Goodhardt, M. J., Curzon, G., Iwangoff, P., Meier-Ruge, W. and Davison, A. N. (1979) Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet i, 11-14.
23. Brandel, J. P., Hirsch, E. C., Hersh, L. B. and Javoy-Agid, F. (1990) Compartmental ordering of cholinergic innervation in the mediodorsal nucleus of the thalamus in human brain. Brain Res. 515, 117-125.
24. Brandel, J. P., Hirsch, E. C., Malessa, S., Duyckaerts, C., Cervera, P. and Agid, Y. (1991) Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsy. Neuroscience 41, 25-31.
25. Buckley, N. J., Bonner, T. I. and Brann, M. R. (1988) Localization of a family of muscarinic receptor mRNAs in rat brain. J. Neurosci. 8, 4646-4652.
26. Buckley, N. J., Bonner, T. I., Buckley, C. M. and Brann, M. R. (1989) Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Molec. Pharmacol. 35, 469-476.
27. Candy, J. M., Perry, R. H., Perry, E. K., Irving, D., Blessed, G., Fairbairn, A. F. and Tomlinson, B. E. (1983) Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J. Neurol. Sci. 59, 277-289.
28. Chiappinelli, V. A. (1986) Actions of snake venom toxins on neuronal nicotinic receptors and other neuronal receptors. Pharmacol. Ther. 31, 1-31.
29. Collerton, D. (1986) Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19, 1-28.
30. Court, J. A., Perry, E. K., Johnson, M., Piggott, M. A., Kerwin, J. A., Perry, R. H. and Ince, P. G. (1993) Regional patterns of cholinergic and glutamate activity in the developing and aging human brain. Dev. Brain Res. 74, 73-82.
31. Cummings, J. L. and Benson, D. F. (1987) The role of the nucleus basalis of Meynert in dementia: review and reconsideration. Alzheimer Dis. Assoc. Disord. 1, 128-155.
32. Danielsson, E., Eckenas, S.-A., Westlind-Danielsson, A., Nordstrom, O., Bartfai, T., Gottfries, C.-G. and Wallin, A. (1988) VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by Alzheimer's disease/senile dementia of the Alzheimer type. Neurobiol. Aging 9, 153-162.
33. Darvesh, S., Grantham, D. and Hopkins, D. A. (1996) Distribution of butyrylcholinesterase in the human forebrain. Soc. Neurosci. Abstr. 22, 201.
34. Davies, P. (1979) Neurotransmitter-related enzymes in senile dementia of the Alzheimer's type. Brain Res. 171, 319-327.
35. Davies, P. and Feisullin, S. (1981) Postmortem stability of alpha-bungarotoxin binding sites in mouse and human brain. Brain Res. 216, 449-454.
36. Davies, P. and Maloney, A. J. F. (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet ii, 1403.
37. Davis, K. L., Mohs, R. C., Tinklenberg, J. R., Davis, B. M., Pfefferbaum, A., Hollister, L. E. and Koppell, B. S. (1978) Physostigmine: improvement of long-term memory process in normal humans. Science 201, 272-274.
38. de Olmos, J. (1990) Amygdala. In: The Human Nervous System, pp. 583-710. Ed. G. Paxinos. Academic Press: New York.
39. De-Lacalle, S., Lim, C., Sobreviela, T., Mufson, E. J., Hersh, L. B. and Saper, C. B. (1994) Cholinergic innervation in the human hippocampal formation including the entorhinal cortex. J. Compar. Neurol. 345, 321-344.
40. DeSarno, P., Giacobini, E., McIlhany, M. and Clark, B. (1988) Nicotinic receptors in human CNS: a biopsy study. In: Proceedings 2nd Intl. Symp. on Senile Dementias, pp. 329-334. Eds A. Agnoli. John Libbey Eurotext.
41. Ehlert, F. J., Roeske, W. R. and Yamamura, H. I. (1994) Muscarinic receptors and novel strategies for the treatment of age-related brain disorders. Life Sci. 55, 2135-2145.
42. Emre, M., Geula, C. and Mesulam, M. M. (1993) Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in Alzheimer's disease. J. Compar. Neurol. 336, 117-134.
43. Esiri, M. M. and Wilcock, G. K. (1984) The olfactory bulbs in Alzheimer's disease. J. Neurol. Neurosurg. Psych. 47, 56-60.
44. Etienne, P., Robitaille, Y., Gauthier, S. and Nair, N. P. (1986a) Nucleus basalis neuronal loss and neuritic plaques in advanced Alzheimer's disease. Can. J. Physiol. Pharmacol. 64, 318-324.
45. Etienne, P., Robitaille, Y., Wood, P., Gauthier, S., Nair, N. P. V. and Quirion, R. (1986b) Nucleus basalis neuronal loss, neuritic plaques, and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience 19, 1279-1291.
46. 2 hydrolysis in Alzheimer's disease. Life Sci. 53, 439-444.
47. Fishman, E. B., Siek, G. C., MacCallum, R. D., Bird, E. D., Volicer, L. and Marquis, J. K. (1986) Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of Alzheimer type. Ann. Neurol. 19, 246-252.
48. Flynn, D. D., Weinstein, D. A. and Mash, D. C. (1991) Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies. Ann. Neurol. 29, 256-262.
49. Flynn, D. D., Ferrari-DiLeo, G., Mash, D. C. and Levey, A. I. (1995a) Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease. J. Neurochem. 64, 1888-1891.
50. Flynn, D. D., Ferrari-DiLeo, G., Levey, A. I. and Mash, D. C. (1995b) Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies. Life Sci. 56, 869-876.
51. Freeman, S. and Dawson, R. M. (1991) Tacrine: A pharmacological review. Prog. Neurobiol. 36, 257-277.
52. 3H]inositol(1,3,4,5)P4 binding in Alzheimer's disease brain. Brain Res. 681, 160-166.
53. German, D. C., Bruce, G. and Hersh, L. B. (1985) Immunohistochemical staining of cholinergic neurons in the human brain using a polyclonal antibody to human choline acetyltransferase. Neurosci. Lett. 61, 1-5.
54. Geula, C. and Mesulam, M. M. (1989) Cortical cholinergic fibers in aging and Alzheimer's disease: a morphometric study. Neuroscience 33, 469-481.
55. Geula, C. and Mesulam, M. M., Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease. In: Alzheimer Disease. pp. 263-291. Eds R. D. Terry, R. Katzman and K. L. Bick. Raven Press: New York.
56. Geula, C., Tokuno, H., Hersh, L. and Mesulam, M. M. (1990) Human striatal cholinergic neurons in development, aging and Alzheimer's disease. Brain Res. 508, 310-312.
57. Giacobini, E. (1990) Cholinergic receptors in human brain: effects of aging and Alzheimer disease. J. Neurosci. Res. 27, 548-560.
58. Giacobini, E. (1991) Nicotinic cholinergic receptors in human brain: effects of aging and Alzheimer. Adv. Exp. Med. Biol. 296, 303-315.
59. Giacobini, E., DeSarno, P., Clark, B. and McIlhany, M. (1989) The cholinergic receptor system of the human brain: neurochemical and pharmacological aspects in aging and Alzheimer. Prog. Brain Res. 79, 335-343.
60. Giacobini, E., Griffini, P. I., Maggi, T., Mascellani, G. and Mandelli, R. (1996) Butyrylcholinesterase: Is it important for cortical acetylcholine regulation? Soc. Neurosci. Abstr. 22, 203.
61. Goldman, D., Simmons, D., Swanson, L. W., Patrick, J. and Heinemann, S. (1986) Mapping of brain areas expressing RNA homologous to two different acetylcholine receptor α-subunit cDNAs. Proc. natn. Acad. Sci. U.S.A. 83, 4076-4080.
62. Goldman, D., Deneris, E., Luyten, W., Kochlar, A., Patrick, J. and Heinemann, S. (1987) Members of the nicotine acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system. Cell 48, 965-973.
63. Gottfries, C. G. (1988) Alzheimer's disease. A critical review. Compar. Gerontol. C2, 47-62.
64. Grant, G. A., Frazier, M. W. and Chiappinelli, V. A. (1988) Amino acid sequence of kappa-flavitoxin: establishment of a new family of snake venom neurotoxins. Biochemistry 27, 3794-3798.
65. Green, R. C. and Mesulam, M. M. (1988) Acetylcholinesterase fiber staining in the human hippocampus and parahippocampus gyrus. J. Compar. Neurol. 273, 488-499.
66. Greenamyre, J. T. and Maragos, W. E. (1993) Neurotransmitter receptors in Alzheimer disease. Cerebrovasc. Brain Metab. Rev. 5, 61-94.
67. Griffiths, P. D., Perry, R. H. and Crossman, A. R. (1994) A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease. Neurosci. Lett. 169, 68-72.
68. Gulya, K., Budai, D. and Kása, P. (1989) Muscarinic autoreceptors are differentially affected by selective muscarinic antagonists. Neurochem. Int. 15, 153-156.
69. Gulya, K., Watson, M., Vickroy, T. W., Roeske, W. R., Perry, R., Perry, E., Duckles, S. P. and Yamamura, H. I. (1986) Examination of cholinergic and neuropeptide receptor alterations in senile dementia of the Alzheimer's type (SDAT). In: Alzheimer's and Parkinson's Diseases. Advances in Behavioral Biology, vol. 29, pp. 109-116. Eds A. Fisher, I. Hanin and C. Lachman. Plenum Press: New York.
70. Halliday, G. M. and Cullen, K. M. (1995) Neurotransmitter changes in Alzheimer's disease, In, Neurotransmitters in the Human Brain, pp. 199-219. Eds D. J. Tracey et al. Plenum Press: New York.
71. Hardy, J. A. and Higgins, G. A. (1992) Alzheimer's disease - the amyloid cascade hypothesis. Science 256, 184-185.
72. Hardy, J., Adolfsson, R., Alafuzoff, I., Bucht, G., Marcusson, J., Nyberg, P., Perdahl, E., Wester, P. and Winblad, B. (1985) Transmitter deficits in Alzheimer's disease. Neurochem. Int. 7, 545-563.
73. Harrison, P. J., Barton, A. J. L., Najlerahim, A., McDonald, B. and Pearson, R. C. A. (1991) Increased muscarinic receptor messenger RNA in Alzheimer's disease temporal cortex demonstrated by in situ hybridization histochemistry. Molec. Brain Res. 9, 15-21.
74. Hebb, C. O. (1956) Choline acetylase in the developing nervous system of the rabbit and guinea-pig. J. Physiol., Lond. 133, 566-570.
75. Heckers, S., Geula, C. and Mesulam, M .M. (1992) Cholinergic innervation of the human thalamus: dual origin and differential nuclear distribution. J. Compar. Neurol. 325, 68-82.
76. Hedreen, J. C., Struble, R. G., Whitehouse, P. J. and Price, D. L. (1984) Topography of the magnocellular basal forebrain system in human brain. J. Neuropath. Exp. Neurol. 43, 1-21.
77. Henke, H. and Lang, W. (1983) Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients. Brain Res. 267, 281-291.
78. Hérnandez-Hérnandez, A., Adem, A., Ravid, R. and Cowburn, R. F. (1995) Preservation of acetylcholine muscarinic M2 receptors G-protein interactions in the neocortex of patients with Alzheimer's disease. Neurosci. Lett. 186, 57-60.
79. Herzog, A. G. and Kemper, T. L. (1980) Amygdaloid changes in aging and dementia. Archs Neurol. 37, 625-629.
80. Hiari, T. and Jones, E. G. (1989) A new parcellation of the human thalamus on the basis of histochemical staining. Brain Res. Rev. 14, 1-34.
81. Hirsch, E. C., Graybiel, A. M., Hersh, L. B., Duyckaerts, C. and Agid, Y. (1989) Striosomes and extrastriosomal matrix contain different amounts of immunoreactive choline acetyltransferase in the human striatum. Neurosci. Lett. 96, 145-150.
82. Holt, D. J., Hersh, L. B. and Sapers, C. B. (1996) Cholinergic innervation in the human striatum: a three-compartment model. Neuroscience 74, 67-87.
83. Inestrosa, N. C., Alvarez, A., Pérez, C. A., Moreno, R. D., Vincente, M., Linker, C., Casanueva, O. I., Soto, C. and Garrido, J. (1996) Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme. Neuron 16, 881-891.
84. Jenni-Eiermann, S., von Hahn, H. P., Honegger, C. G. and Ulrich, J. (1984) Studies on neurotransmitter binding in senile dementia. Gerontology 30, 350-358.
85. Kása, P. (1986) The cholinergic systems in brain and spinal cord. Prog. Neurobiol. 26, 211-272.
86. Kása, P., Hlavati, I., Dobó, E., Wolff, A., Joó, F. and Wolff, J. R. (1995) Synaptic and non-synaptic cholinergic innervation of the various types of neurons in the main olfactory bulb of adult rat: immunocytochemistry of choline acetyltransferase. Neuroscience 67, 667-677.
87. Kása, P., Karcsu, S., Kovacs, I. and Wolff, J. R. (1996) Cholinoceptive neurons without acetylcholinesterase activity and enzyme-positive neurons without cholinergic synaptic innervation are present in the main olfactory bulb of adult rat. Neuroscience 73, 831-844.
88. Kellar, K. J., Whitehouse, P. J., Martino-Barrows, A. M., Marcus, K. and Price, D. L. (1987) Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex. Brain Res. 436, 62-68.
89. Kemper, T. L. (1983) Organization of the neuropathology of the amygdala in Alzheimer's disease, in: Banbury Report 15: Biological Aspects of Alzheimer's Disease, pp. 31-35. Ed. R. Katzman. Cold Spring Harbor Laboratory: New York.
90. Kobayashi, K., Miyazu, K., Fukutani, Y., Nakamura, I. and Yamaguchi, N. (1991) Morphometric study on the Ch4 of the nucleus basalis of Meynert in Alzheimer's disease. Molec. Chem. Neuropath. 15, 193-205.
91. Koelle, G. B. and Friedenwald, J. S. (1949) A histochemical method for localizing cholinesterase activity. Proc. Soc. Exp. Biol. Med. 70, 617-622.
92. Koshimura, K., Kato, T., Yohyama, I., Nakamura, S. and Kameyama, M. (1987) Correlation of choline acetyltransferase activity between the nucleus basalis of Meynert and the cerebral cortex. Neurosci. Res. 4, 330-336.
93. Kovács, I., Török, I., Zombori, J. and Kása, P. (1996a) Neuropathologic changes in the olfactory bulb in Alzheimer's disease. Neurobiology 4, 123-126.
94. Kovács, I., Török, I., Zombori, J. and Kása, P. (1996b) Cholinergic structures and neuropathological changes in human olfactory bulb. Clin. Neurosci. 49, 23-24.
95. Kromer-Vogt, L. J., Hyman, B. T., van Hoesen, G. W. and Damasio, A. R. (1990) Pathological alterations in the amygdala in Alzheimer's disease. Neuroscience 37, 377-385.
96. Kubo, T., Fukuda, K., Mikami, A., Maeda, A., Takahasi, H., Mishina, M., Haga, K., Ichiyama, A., Kangawa, K., Kojima, M., Matsuo, H., Hirose, T. and Numa, S. (1986) Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature 323, 411-416.
97. Ladner, C. J., Celesia, G. G., Magnuson, D. J. and Lee, J. M. (1995) Regional alterations in M1 muscarinic receptor-G protein coupling in Alzheimer's disease. J. Neuropath. Exp. Neurol. 54, 783-789.
98. Lang, W. and Henke, H. (1983) Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients. Brain Res. 267, 271-280.
99. Lange, K. W., Wells, F. R., Rossor, M. N., Jenner, P. and Marsden, C. D. (1991) Cortical nicotinic receptors in Alzheimer's disease and Parkinson's disease. Lancet i, 373-374.
100. Le Jeune, H. and Jourdan, F. (1993) Cholinergic innervation of olfactory glomeruli in the rat: an ultrastructural immunocytochemical study. J. Compar. Neurol. 336, 279-292.
101. Le Jeune, H. and Jourdan, F. (1994) Acetylcholinesterase-containing intrinsic neurons in the rat main olfactory bulb: cytological and neurochemical features. Eur. J. Neurosci. 6, 1432-1444.
102. Lehéricy, S., Hirsch, E. C. and Cervera, P. et al. (1989) Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer's disease. Proc. natn. Acad. Sci. U.S.A. 86, 8580-8584.
103. Lehéricy, S., Hirsch, E. C. and Cervera-Pierot, P. et al. (1993) Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J. Compar. Neurol. 330, 15-31.
104. Levey, A. (1996) Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer's disease. Proc. natn. Acad. Sci. U.S.A. 93, 13541-13546.
105. London, E. D. and Waller, S. B. (1986) Relationships between choline acetyltransferase and muscarinic binding in aging rodent brain and in Alzheimer's disease. In: Dynamics of Cholinergic Function, pp. 215-224. Ed. I. Hanin. Plenum Press: New York.
106. London, E. D., Ball, M. J. and Waller, S. B. (1989) Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia. Neurochem. Res. 14, 745-750.
107. Lysakowski, A., Wainer, B. H., Bruce, G. and Hersh, L. B. (1989) An atlas of the regional and laminar distribution of choline acetyltransferase immunoreactivity in rat cerebral cortex. Neuroscience 28, 291-336.
108. Maelicke, A. (1988) Structure and function of the nicotinic acetylcholine receptors. In, The Cholinergic Synapse - Handbook of Experimental Pharmacology, vol. 86, pp. 267-313. Ed. V. P. Whittaker, Springer: Berlin.
109. Mann, D. M. A., Tucker, C. M. and Yates, P. O. (1988) Alzheimer's disease, An olfactory connection? Mechanisms Ageing Develop 42, 1-15.
110. Mash, D. C., Flynn, D. D. and Potter, L. T. (1985) Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228, 1115-1117.
111. Masliah, E., Terry, R. and Buzsáki, G. (1989) Thalamic nuclei in Alzheimer disease. Evidence against the cholinergic hypothesis of plaque formation. Brain Res. 493, 240-246.
112. McGeer, P. L., McGeer, E. G., Suzuki, J., Dolman, C. E. and Nagai, T. (1984) Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurology 34, 741-745.
113. McKinney, M. and Coyle, J. T. (1991) The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimer's disease. Mayo Clin. Proc. 66, 1225-1237.
114. Mellgren, S. I., Harkmark, W. and Srebro, B. (1977) Some enzyme histochemical characteristics of the human hippocampus. Cell Tiss. Res. 181, 459-471.
115. Mesulam, M. M. (1986) Alzheimer plaques and cortical cholinergic innervation. Neuroscience 17, 275-276.
116. Mesulam, M. M. and Geula, C. (1988a) Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain. Observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J. Compar. Neurol. 275, 216-240.
117. Mesulam, M. M. and Geula, C. (1988b) Acetylcholinesterase-rich pyramidal neurons in the human neocortex and hippocampus: absence at birth, development during the life span, and dissolution in Alzheimer's disease. Ann. Neurol. 24, 765-773.
118. Mesulam, M. M. and Geula, C. (1991) Acetylcholinesterase-rich neurons of the human cerebral cortex: cytoarchitectonic and ontogenetic patterns of distribution. J. Compar. Neurol. 306, 193-220.
119. Mesulam, M. M. and Geula, C. (1992) Overlap between acetylcholinesterase-rich and choline acetyltransferase-positive (cholinergic) axons in human cerebral cortex. Brain Res. 577, 112-120.
120. Mesulam, M. M., Mufson, E. J., Levey, A. I. and Wainer, B. H. (1983) Alzheimer's disease and the cholinergic innervation of the neocortex by the nucleus hasalis of Meynert (Ch4). In: Banbury Report 15: Biological Aspects of Alzheimer's Disease, pp. 79-88. Ed. R. Katzman. Cold Spring Harbor Laboratory: New York.
121. Mesulam, M. M., Mufson, E. J., Levey, A. I. and Wainer, B. H. (1984) Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetyltransferase histochemistry. Neuroscience 12, 669-686.
122. Mesulam, M. M., Geula, C., Bothwell, M. A. and Hersh, L. B. (1989) Human reticular formation: Cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons. J. Compar. Neurol. 281, 611-633.
123. Mesulam, M. M., Geula, C., Cosgrove, R., Mash, D. and Brimijoin, S. (1991) Immunocytochemical demonstration of axonal and perikaryal acetylcholinesterase in human cerebral cortex. Brain Res. 539, 233-238.
124. Mesulam, M. M., Hersh, L. B., Mash, D. C. and Geula, C. (1992a) Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: a choline acetyltransferase study. J. Compar. Neurol. 318, 316-328.
125. Mesulam, M. M., Mash, D., Hersh, L., Bothwell, M. and Geula, C. (1992b) Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia, nigra, and red nucleus. J. Compar. Neurol. 323, 252-268.
126. Mishkin, M. (1978) Memory in monkeys severely impaired by combined but not separate removals of the amygdala and hippocampus. Nature 273, 297-298.
127. Mizukawa, K., McGeer, P. L., Tago, H., Peng, J. H., McGeer, E. G. and Kimura, H. (1986) The cholinergic system of the human hindbrain studied by choline acetyltransferase immunohistochemistry. Brain Res. 379, 39-55.
128. Nagai, T., McGeer, P. L., Peng, J. H., McGeer, E. G. and Dolman, C. E. (1983a) Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls. Neurosci. Lett. 36, 195-199.
129. Nagai, T., Pearson, T., Peng, F., McGeer, E. G. and McGeer, P. L. (1983b) Immunohistochemical staining of the human forebrain with monoclonal antibody to human choline acetyltransferase. Brain Res. 265, 300-306.
130. Nakamura, S., Kawashima, S., Nakano, S., Tsuji, T. and Araki, W. (1990) Subcellular distribution of acetylcholinesterase in Alzheimer's disease: abnormal localization and solubilization. J. Neural Transm., (Suppl.) 30, 13-23.
131. Nakayama, H., Nakashima, T. and Kurogochi, Y. (1991) α4 is a major acetylcholine binding subunit of cholinergic ligand-affinity purified nicotinic acetylcholine receptor from rat brains. Neurosci. Lett. 121, 122-124.
132. Neary, D., Snowden, J., Mann, D., Bowen, D., Simms, N., Northen, B., Yates, P. and Davison, A. (1986) Alzheimer's disease: A correlative study. J. Neurol. Neurosurg. Psych. 49, 229-237.
133. Neff, P., Oneyser, C., Alliod, C., Couturier, S. and Ballivet, M. (1988) Genes expressed in the brain define three distinct neuronal nicotinic acetylcholine receptors. Eur. Molec. Biol. Org. J. 7, 595-601.
134. Nordberg, A. (1992a) Biological markers and the cholinergic hypothesis in Alzheimer's disease. Acta Neurol. Scand. 139, 54-58.
135. Nordberg, A. (1992b) Neuroreceptor changes in Alzheimer disease. Cerebrovasc. Brain Metab. Rev. 4, 303-328.
136. Nordberg, A. (1993) Clinical studies in Alzheimer patients with positron emission tomography. Behav. Brain Res. 57, 215-224.
137. 3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci. Lett. 72, 115-119.
138. 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography. J. Neural Transm. 2, 215-224.
139. Nordberg, A., Lilja, A., Lundqvist, H., Hartvig, P., Amberla, K., Viitanen, M., Warpman, Y., Johansson, M., Hellstron-Lindahl, E. and Bjurling, P. et al. (1992) Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography. Neurobiol. Aging 13, 747-758.
140. Nordberg, A., Lundqvist, H., Hartvig, P., Lilja, A. and Langstrom, B. (1995) Kinetic analysis of regional (S)-11C-nicotine binding in normal and Alzheimer brains - in vivo assessment using positron emission tomography. Alzheimer Dis. Assoc. Disord. 9, 21-27.
141. Nyback, H., Nordberg, A., Langstrom, B., Halldin, C., Hartvig, P., Ahlin, A., Swan, C-G. and Sedvall, G. (1989) Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography. In: Progress in Brain Research, vol. 79. pp. 313-319. Eds. A. Nordberg, K. Fuxe, B. Holmstedt, A. Sundwall. Elsevier: Amsterdam.
142. Ogane, N., Giacobini, E. and Struble, R. (1992) Differential inhibition of acetylcholinesterase molecular forms in normal and Alzheimer disease brain. Brain Res. 589, 307-312.
143. Ohara, K., Kondo, N., Xie, D., Tanabe, K., Yamamoto, T., Kosaka, K., Miyasato, K. and Ohara, K. (1994) Normal sequences of muscarinic acetylcholine receptors (m1 and m2) in patients with Alzheimer's disease and vascular dementia. Neurosci. Lett. 178, 23-26.
144. Ohm, T. G., Braak, E. and Probst, A. (1988a) Somatostatin-14-like immunoreactive neurons and fibres in the human olfactory bulb. Anat. Embryol. 179, 165-172.
145. Ohm, T. G., Braak, E., Probst, A. and Weindl, A. (1988b) Neuropeptide Y-like immunoreactive neurons in the human olfactory bulb. Brain Res. 451, 295-300.
146. Ohye, C. (1990) Thalamus, In: The Human Nervous System, pp. 439-468. Ed. G. Paxinos. Academic Press: New York.
147. Olson, L., Nordberg, A., von Holst, H., Backman, L., Ebendal, T., Alafuzoff, I., Amberla, K., Hartvig, P., Herlitz, A. and Lilja, A. et al. (1992) Nerve growth factor effects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient. J. Neural Transm. 4, 79-95.
148. Oyanagi, K., Takahashi, H., Wakabayashi, K. and Ikuta, F. (1987) Selective involvement of large neurons in the neostriatum of Alzheimer's disease and senile dementia: a morphometric investigation. Brain Res. 411, 205-211.
149. Oyanagi, K., Takahashi, H., Wakabayashi, K. and Ikula, F. (1989) Correlative decrease of large neurons in the neostriatum and basal nucleus of Meynert in Alzheimer's disease. Brain Res. 504, 354-357.
150. Oyanagi, K., Takahashi, H., Wakabayashi, K. and Ikuta, F. (1991) Large neurons in the neostriatum in Alzheimer's disease and progressive supranuclear palsy: a topographic, histologic and ultrastructural investigation. Brain Res. 544, 221-226.
151. Palmer, A. M. and Bowen, D. M. (1990) Neurochemical basis of dementia of the Alheimer type: contribution of postmortem and antemortem studies. In: Biological Markers of Dementia of Alzheimer Type: Proceedings of the Stiftelsen Gamla Tjänarinnor Symposium on Aging and Aging Disorders, No. 1, pp. 89-105. Eds C. Fowler, L. A. Carlson, C. G. Gottfries and B. Winblad. Smith-Gordon: London.
152. Palmer, A. M. and Gershon, S. (1990) Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic? Fedn Am. Socs Exp. Biol. J. 4, 2745-2752.
153. Palmer, A. M., Procter, A. W., Stratmann, G. C. and Bowen, D. M. (1986) Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease. Neurosci. Lett. 66, 199-204.
154. Pappata, S., Tavitian, B., Traykov, L., Jobert, A., Dalger, A., Mangin, J. F., Crouzel, C. and Di Giamberardino, L. (1996) In vivo imaging of human cerebral acetylcholinesterase. J. Neurochem. 67, 876-879.
155. Parent, A., Csonka, C. and Etienne, P. (1984) The occurrence of large acetylcholinesterase-containing neurons in human neostriatum as disclosed in normal and Alzheimer-diseased brains. Brain Res. 291, 154-158.
156. Pearce, B. D. and Potter, L. T. (1991) Coupling of m1 muscarinic receptors to G protein in Alzheimer disease. Alzheimer Dis. Assoc. Discord. 5, 163-172.
157. Pearson, R. C., Sofroniew, M. V., Cuello, A. C., Powell, T. P., Eckenstein, F., Esiri, M. M. and Wilcock, G. K. (1983) Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res. 289, 375-379.
158. Peralta, E. G., Askhenazi, A., Winslow, J. W., Smith, D. H., Ramachandran, J. and Capon, D. J. (1987) Distinct primary structures, ligand binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. Eur. Molec. Biol. Org. J. 6, 3923-3929.
159. Perry, E. (1986) The cholinergic hypothesis - ten years on. Br. Med. Bull. 42, 63-69.
160. Perry, E. K., Gibson, P. H., Blessed, G., Perry, R. H. and Tomlinson, B. E. (1977) Neurotransmitter enzyme abnormalities in senile dementia. J. Neurol. Sci. 34, 247-265.
161. Perry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H. and Perry, R. H. (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2, 1457-1459.
162. Perry, R. H., Candy, J. M. and Perry, P. K. et al. (1982) Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci. Lett. 33, 311-315.
163. Perry, E. K., Perry, R. H., Smith, C. J., Purohit, D., Bonham, J., Dick, D. J., Candy, J. M., Edwardson, J. A. and Fairbrairn, A. (1986) Cholinergic receptors in cognitive disorders. Can. J. Neurol. Sci. 13, 521-527.
164. Perry, E. K., Smith, C. J., Court, J. A. and Perry, R. H. (1990) Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. J. Neural Transm. 2, 149-158.
165. Perry, E. K., Johnson, M., Kerwin, J. M., Piggott, M. A., Court, J. A., Shaw, P. J., Ince, P. G., Brown, A. and Perry, R. H. (1992) Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol. Aging 13, 393-400.
166. Perry, E. K., Morris, C. M., Court, J. A., Cheng, A., Fairbairn, A. F., McKeith, I. G., Irving, D., Brown, A. and Perry, R. H. (1995) Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience 64, 385-395.
167. Price, J. (1990) Olfactory system. In: The Human Nervous System, pp. 979-998. Ed. G. Paxinos. Academic Press: New York.
168. Probst, A., Cortes, R., Ulrich, J. and Palacios, J. M. (1988) Differential modification of muscarinic cholinergic receptors in the hippocampus of patients with Alzheimer's disease: an autoradiographic study. Brain Res. 450, 190-201.
169. Quirion, R. (1993) Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release. J. Psych. Neurosci. 18, 226-234.
170. Quirion, R., Martel, J. C., Robitaille, Y., Etienne, P., Wood, P., Nair, N. P. and Gauthier, S. (1986) Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type. Can. J. Neurol. Sci. 13, 503-510.
171. 3H-acetylcholine muscarinic receptors in mammalian brain. Apparent labeling of an M2-like receptor subtype. Neuroscience 29, 271-289.
172. Quirion, R., Aubert, I., Lapchak, P. A., Schaum, R. P., Teolis, S., Gauthier, S. and Araujo, D. M. (1989b) Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease, Trends Pharmacol. Sci., Suppl. 5, pp. 80-84.
173. Quirion, R., Aubert, I., Robitaille, Y., Gauthier, S., Araujo, D. M. and Chabot, J. G. (1990) Neurochemical deficits in pathological brain aging: specificity and possible relevance for treatment strategies. Clin. Neuropharmacol. 13, 573-580.
174. Rakonczay, Z. (1986) Mammalian brain acetylcholinesterase. In: Neuromethods, Neurotransmitter Enzymes. vol. 5. pp. 319-360. Eds A. A. Boulton, G. B. Baker and P. H. Yu. Humana Press Inc.: Clifton, New Jersey.
175. Rakonczay, Z. and Brimijoin, S. (1988a) Biochemistry and pathophysiology of the molecular forms of cholinesterases. In: Subcellular Biochemistry, pp. 335-378. Ed. J. R. Harris. Plenum Press: New York.
176. Rakonczay, Z. and Brimijoin, S. (1988b) Monoclonal antibodies to human brain acetylcholinesterase: properties and applications. Cell. Molec. Neurobiol. 8, 85-93.
177. Ransmayr, G., Cervera, P. and Hirsch, E. et al. (1989) Choline acetyltransferase-like immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer's disease. Neuroscience 32, 701-714.
178. Ransmayr, G., Cervera, P., Hirsch, E. C., Berger, W., Fischer, W. and Agid, Y. (1992) Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology? Neuroscience 47, 843-851.
179. Rasool, C. G., Svendsen, C. N. and Selkoe, D. J. (1986) Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease. Ann. Neurol. 20, 482-488.
180. Reinikainen, K. J., Riekkinen, P. F., Halonen, T. and Laakso, M. (1987) Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease. Life Sci. 41, 453-461.
181. Reinikainen, K. J., Soininen, H. and Riekkinen, P. J. (1990) Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy. J. Neurosci. Res. 27, 576-586.
182. Reyes, P. F., Deems, D. A. and Suarez, M. G. (1993) Olfactory-related changes in Alzheimer's disease - a quantitative neuropathologic study. Brain Res. Bull. 32, 1-5.
183. Richter, J. A., Perry, E. K. and Tomlinson, B. E. (1980) Decreased acetylcholine content in Alzheimer's disease. Life Sci. 26, 1683-1689.
184. Rinne, J. O., Rinne, J. K., Laakso, K., Paljarvi, L. and Rinne, U. K. (1984) Reduction of muscarinic receptor binding in limbic areas of Alzheimer brain. J. Neurol. Neurosurg. Psych. 47, 651-653.
185. Rinne, J. O., Laakso, K., Lonnberg, P., Molsa, P., Paljarvi, L., Rinne, J. K., Sako, E. and Rinne, U. K. (1985) Brain muscarinic receptors in senile dementia. Brain Res. 336, 19-25.
186. Rinne, J. O., Paljarvi, L. and Rinne, U. K. (1987) Neuronal sites and density in the nucleus basalis of Meynert in Alzheimer's disease. J. Neurol. Sci. 79, 67-76.
187. Rinne, J. O., Lönnberg, P., Marjamaki, P. and Rinne, U. K. (1989) Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease. Brain Res. 483, 402-406.
188. Rinne, J. O., Myllykyla, T., Lönnberg, P. and Marjamaki, P. (1991) A post mortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease. Brain Res. 547, 167-170.
189. Rogers, J. D., Brogan, D. and Mirra, S. S. (1985) The nucleus basalis of Meynert in neurological disease: a quantitative morphological study. Ann. Neurol. 17, 163-170.
190. Rogers, S. L. and Friedhoff, L. T. (1996) The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, randomized, double-blind, placebo-controlled trial. Dementia 7, 293-303.
191. Rossor, M. N., Garett, N. J., Johnson, A. L., Mountjoy, C. Q., Roth, M. and Iversen, L. L. (1982a) A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain 105, 313-330.
192. Rossor, M. N., Svendsen, C., Hunt, S. P., Mountjoy, C. Q., Roth, M. and Iversen, L. L. (1982b) The substantia innominata in Alzheimer's disease: An histochemical and biochemical study of cholinergic marker enzymes. Neurosci. Lett. 28, 217-222.
193. Rubboli, F., Court, J. A., Sala, C., Morris, C., Perry, E. and Clementi, F. (1994) Distribution of neuronal nicotinic receptor subunits in human brain. Neurochem. Int. 25, 69-71.
194. Rylett, R. J., Ball, M. J. and Colhoun, E. H. (1983) Evidence for high-affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease. Brain Res. 289, 169-175.
195. Sakurada, T., Alufuzoff, I., Windblad, B. and Nordberg, A. (1990) Substance P-like immunoreactivity, choline acetyltransferase, activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia. Brain Res. 521, 329-332.
196. Saper, C. B. (1990) Cholinergic system. In: The Human Nervous System, pp. 1095-1113. Ed. G. Paxinos. Academic Press: New York.
197. Saper, C. B. and Chelimsky, T. C. (1984) A cytoarchitectonic and histochemical study of nucleus basalis and associated cell groups in the normal human brain. Neuroscience 13, 1023-1037.
198. Saper, C. B., German, D. C. and White, C. L. (1985) Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer's type: Possible role in cell loss. Neurology 35, 1089-1095.
199. Sargent, P. B. (1993) The diversity of neuronal acetylcholine receptors. A. Rev. Neurosci. 16, 403-443.
200. Schneider, M., Adee, C., Betz, H. and Schmidt, J. (1985) Biochemical characterization of two nicotinic receptors from the optic lobe of the chick. J. Biol. Chem. 260, 14505-14512.
201. Schröder, H., Giacobini, E., Struble, R. G., Zilles, K. and Maelicke, A. (1991a) Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease. Neurobiol. Aging 12, 259-262.
202. Schröder, H., Giacobini, E., Struble, R. G., Zilles, K., Maelicke, A., Luiten, P. G. and Strosberg, A. D. (1991b) Cellular distribution and expression of cortical acetylcholine receptors in aging and Alzheimer's disease. Ann. N. Y. Acad. Sci. 640, 189-192.
203. Schröder, H., Giacobini, E., Wevers, A., Birtsch, C. and Schütz, U. (1995) Nicotinic receptors in Alzheimer's disease. In: Brain Imaging of Nicotine and Tobacco Smoking. pp. 73-93. Eds E. F. Domino, NPP Books: Ann Arbor.
204. Schubiger, P. A. (1992) New receptor ligands for single-photon emission tomography of the brain. Schweiz. Med. Wochenschr. 122, 1678-1688.
205. Scott, S. A., De Kosky, S. T. and Scheff, S. W. (1991) Volumetric atrophy of the amygdala in Alzheimer's disease: quantitative serial reconstruction. Neurology 41, 351-356.
206. Selden, N., Geula, C., Hersh, L. and Mesulam, M.-M. (1994) Human striatum: chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease. Neuroscience 60, 621-636.
207. Shen, Z. X. (1994) Acetylcholinesterase provides deeper insights into Alzheimer's disease. Med. Hypotheses 43, 21-30.
208. Shimohama, S., Taniguchi, T., Fujiwara, M. and Kameyama, M. (1986) Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia. J. Neurochem. 46, 288-293.
209. Siek, G. C., Katz, L. S., Fishman, E. B., Korosi, T. S. and Marquis, J. K. (1990) Molecular forms of acetylcholinesterase in subcortical areas of normal and Alzheimer's disease brain. Biol. Psychiatry 27, 573-580.
210. Simpson, J., Yates, C. M., Gordon, A. and St. Clair, D. M. (1984) Olfactory tubercle choline acetyltransferase activity in Alzheimer-type dementia, Down's syndrome and Huntington's chorea. J. Neurol. Neurosurg. Psych. 47, 1138-1139.
211. Sims, K. S. and Williams, R. S. (1990) The human amygdaloid complex: a cytologic and histochemical atlas using Nissl, myelin, acetylcholinesterase and nicotinamide adenine dinucleotide phosphate diaphorase staining. Neuroscience 36, 449-472.
212. Sims, S., Bowen, D. M. and Smith, C. C. T. et al. (1980) Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease. Lancet i, 333-336.
213. Smith, C. J., Perry, E. K., Perry, R. H., Fairbairn, A. F. and Birdsall, N. J. M. (1987) Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain - a preliminary study in Alzheimer's disease. Neurosci. Lett. 82, 227-232.
214. Smith, C. J., Perry, E. K., Perry, R. H., Candy, J. M., Johnson, M., Bonham, J. R., Dick, D. J., Fairbairn, A., Blessed, G. and Birdsall, N. J. (1988) Muscarinic cholinergic receptor subtypes in hippocampus in human cognitive disorders. J. Neurochem. 50, 847-856.
215. Smith, R. L., Baker, H. and Greer, C. A. (1993) Immunohistochemical analyses of the human olfactory bulb. J. Compar. Neurol. 333, 519-530.
216. Sparks, D. L., Hulsaker, J C., Slevin, J. T., De Kosky, S. T., Kryscio, R. J. and Markesbery, W. R. (1992) Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (M): normal age-related changes and the effect of heart disease and Alzheimer's disease. Ann. Neurol. 31, 611-620.
217. Strada, O., Vyas, S. and Hirsch, E. C. et al. (1992) Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer's disease: an in situ hybridization study. Proc. natn. Acad. Sci. U.S.A. 89, 9549-9553.
218. Struble, R. G. and Clark, B. (1992) Olfactory bulb lesions in Alzheimer's disease. Neurobiol. Aging 13, 469-473.
219. Sugaya, K., Giacobini, E. and Chiappinelli, V. A. (1990) Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease. J. Neurosci. Res. 27, 349-359.
220. Summers, W. K., Majovski, L. V., Marsh, G. M., Tachiki, K. and Kling, A. (1986) Oral tetrahydroaminoacridine in long-term treatment of senile dementia Alzheimer's type. N. Engl. J. Med. 315, 1241-1245.
221. Sunderland, T., Esposito, G., Molchan, S. E., Coppola, R., Jones, D. W., Gorey, J., Little, J. T., Bahro, M. and Weinberger, D. R. (1995) Differential cholinergic regulation in Alzheimer's patients compared to controls following chronic blockade with scopolamine: a SPECT study. Psychopharmacology 121, 231-241.
222. Sutoo, D., Akiyama, K., Yabe, K. and Kohno, K. (1994) Quantitative analysis of immunohistochemical distributions of cholinergic and catecholaminergic systems in the human brain. Neuroscience 58, 227-234.
223. Svendsen, C. N. and Bird, E. D. (1985) Acetylcholinesterase staining of the human amygdala. Neurosci. Lett. 54, 313-318.
224. Tago, H., Kimura, H. and Maeda, T. (1986) Visualization of detailed acetylcholinesterase fiber and neuron staining in rat brain by a sensitive histochemical procedure. J. Histochem. Cytochem. 34, 1431-1438.
225. Tago, H., McGeer, P. L. and McGeer, E. G. (1987) Acetylcholinesterase fibers and the development of senile plaques. Brain Res. 406, 363-369.
226. ter-Laak, H. J., Renkawek, K. and van-Workum, F. P. (1994) The olfactory bulb in Alzheimer disease: a morphologic study of neuron loss, tangles, and senile plaques in relation to olfaction. Alzheimer Dis. Assoc. Disord. 8, 38-48.
227. Vágvölgyi, J., Bodosi, M., Hlavati, I., Karcsú, S. and Kása, P. (1991) Lack of correlation between plaque numbers and acetylcholinesterase-positive axons in the temporal cortex and hippocampus of the Alzheimer's disease brain. First Hungarian Conference on Alzheimer's Disease, Abstr. 50.
228. Vogels, O. J. M., Broere, C. A. J., Ter Laak, H. J., Ten Donkelaar, H. J., Nieuwenhuys, R. and Schulte, B. P. M. (1990) Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol. Aging 11, 3-13.
229. Vogt, B. A., Crino, P. B. and Vogt, L. J. (1992) Reorganization of cingulate cortex in Alzheimer's disease: neuron loss, neuritic plaques, and muscarinic receptor binding. Cerebral Cortex 2, 526-535.
230. Volicer, L. and Crino, P. B. (1990) Involvement of free radicals in dementia of the Alzheimer type: a hypothesis. Neurobiol. Aging 11, 567-571.
231. Wagner, H. N. (1986) Quantitative imaging of neuroreceptors in the living human brain. Semin. Nucl. Med. 16, 51-62.
232. Waller, S. B., Ball, M. J., Reynolds, M. A. and London, E. D. (1986) Muscarinic binding and choline acetyltransferase in postmortem brains of demented patients. Can. J. Neurol. Sci. 13, 528-532.
233. Wang, H. Y. and Friedman, E. (1994) Receptor-mediated activation of G proteins is reduced in postmortem brains from Alzheimer's disease patients. Neurosci. Lett. 173, 37-39.
234. Wang, J-X., Gulya, K., Vickroy, T. W., Mei, L., Roeske, W. R., Perry, E. K., Perry, R., Fibiger, H. and Yamamura, H. I. (1986) Alterations of cholinergic and somatostatin systems in Alzheimer's disease and its animal models. In: Liver and Aging-1986, Liver and Brain, pp. 209-220. Ed. K. Kitani, Elsevier: Amsterdam.
235. 3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart. Life Sci. 41, 1751-1760.
236. Wang, S. Z., Zhu, S. Z., Mash, D. C. and El-Fakahany, E. E. (1992) Comparison of the concentration of messenger RNA encoding four muscarinic receptor subtypes in control and Alzheimer brains. Molec. Brain Res. 16, 64-70.
237. Warpman, U. and Nordberg, A. (1995) Epibatidine and ABT 418 reveal selective losses of α4β2 nicotinic receptors in Alzheimer brains. Neuro Report 6, 2419-2423.
238. Warpman, U., Alafuzoff, I. and Nordberg, A. (1993a) Defective coupling of muscarinic receptors to GTP-binding proteins in Alzheimer's brains. In: Alzheimer's Disease: Advances in Clinical and Basic Research. pp. 291-298. Eds B. Corain, K. Iqbal, M. Nicolini, B. Winblad, H. Wisniewski and P. Zatta. John Wiley and Sons: New York.
239. Warpman, U., Alafuzoff, I. and Nordberg, A. (1993b) Coupling of muscarinic receptors to GTP proteins in postmortem human brain - alterations in Alzheimer's disease. Neurosci. Lett. 150, 39-43.
240. 3H]pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex. Life Sci. 31, 2019-2023.
241. 3H]pirenzepine in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes. Life Sci. 32, 3001-3011.
242. Watson, M., Vickroy, T. W., Roeske, W. R. and Yamamura, H. I. (1985) Functional and biochemical basis for multiple muscarinic acetylcholine receptors. Prog. Neuropsychopharm. Biol. Psych. 9, 569-574.
243. Watson, M., Roeske, W. R., Vickroy, T. W., Smith, T. L., Akiyama. K., Gulya, K., Duckles, S. P., Serra, M., Adem, A., Nordberg, A., Gehlert, D. R., Wamsley, J. K. and Yamamura, H. I. (1986) Biochemical and functional basis of putative muscarinic receptor subtypes and its implications. Trends Pharmacol. Sci. SII, 46-55.
244. 123I-QNB and single photon emission computed tomography. Archs Neurol. 48, 169-176.
245. Weinberger, D. R., Jones, D., Reba, R. C. Mann, U., Coppola, R., Gibson, R., Gorey, J., Braun, A. and Chase, T. N. (1992) A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia. J. Neuropsych. Clin. Neurosci. 4, 239-248.
246. Wevers, A., Jeske, A., Lobron, C., Birtsch, C., Heinemann, S., Maelicke, A., Schröder, R. and Schröder, H. (1994) Cellular distribution of nicotinic acetylcholine receptor subunit mRNAs in the human cerebral cortex as revealed by non-isotopic in situ hybridization. Molec. Brain Res. 25, 122-128.
247. White, P., Hiley, C. R., Goodhardt, M. J., Carrasco, L. H., Keet, J. P., Williams, I. E. and Bowen, D. M. (1977) Neocortical cholinergic neurons in elderly people. Lancet i, 668-671.
248. Whitehouse, P. J. and Au, K. S. (1986) Cholinergic receptors in aging and Alzheimer's disease. Prog. Neuropsychopharm. Biol. Psych. 10, 665-676.
249. Whitehouse, P. J. and Kalaria, R. N. (1995) Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications. Alzheimer Dis. Assoc. Disord. 9, 3-5.
250. Whitehouse, P. J. and Kellar, K. J. (1987) Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders. J. Neural Transm. 24, 175-182.
251. Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T. and de Long, M. R. (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10, 122-126.
252. Whitehouse, P. J., Price, D. L., Struble, R. G., Clark, A. W., Coyle, J. T. and DeLong, M. R. (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215, 1239-1297.
253. Whitehouse, P. J., Martino, A. M., Antuono, P. G., Lowenstein, P. R., Coyle, J. T., Price, D. L. and Kellar, K. J. (1986) Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res. 371, 146-151.
254. 3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology 38, 720-723.
255. Wilcock, G. K., Esiri, M. M., Bowen, D. M. and Smith, C. C. T. (1983) The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry. Neuropathol. Appl. Neurobiol. 9, 175-179.
256. Wilcock, G. K., Esiri, M. M., Bowen, D. M. and Hughes, A. O. (1988) The differential involvement of subcortical nuclei senile dementia of Alzheimer's type. J. Neurol. Neurosurg. Psych. 51, 842-849.
257. Wood, P. L., Etienne, P., Lal, S., Nair, N. P. V., Finlayson, M. H., Gauthier, S., Palo, J., Haltia, M., Paetau, A. and Bird, E. D. (1983) A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease. J. Neurol. Sci. 62, 211-217.
258. Woolf, N. J. and Butcher, L. L. (1990) Dysdifferentiation of structurally plastic neurons initiates the pathological cascade of Alzheimer's disease: toward a unifying hypothesis. In: Brain Cholinergic Systems. pp. 387-438. Eds M. Steriade and D. Biesold. Oxford University Press: Oxford.
259. Woolf, N. J., Jacobs, R. W. and Butcher, L. L. (1989) The pontomesencephalotegmental cholinergic system does not degenerate in Alzheimer's disease. Neurosci. Lett. 96, 277-282.
260. Xuereb, J. H., Perry, E. K., Candy, J. M., Bonham, J. R., Perry, R. H. and Marshall, E. (1990) Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease. J. Neurol. Sci. 99, 185-197.
261. Yamaguchi, H., Haga, G., Hirai, S., Nakazato, Y. and Kosaka, K. (1990) Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brains by a new methenamine silver stain. Acta Neuropathol. 79, 569-572.
262. Younkin, S. G., Goodridge, B., Katz, J., Lockett, G., Nafziger, D., Usiak, M. F. and Younkin, L. H. (1986) Molecular forms of acetylcholinesterase in Alzheimer's disease. Fedn Proc. 45, 2982-2988.
263. Zilles, K. (1990) Cortex. In: The Human Nervous System, pp. 757-802. Ed. G. Paxinos. Academic Press: New York.
264. Zombori, J., Kovács, I., Török, I. and Kása, P. (1996) Structural localization of amyloid β-peptide in the olfactory bulb of Alzheimer's disease brain samples. Clin. Neurosci. 49, 46-47.
265. Zubenko, G. S., Moossy, J., Martinez, A. J., Rao, G. R., Kopp, U. and Hanin, I. (1989) A brain regional analysis of morphologic and cholinergic abnormalities in Alzheimer's disease. Archs Neurol. 46, 634-638.